SG10202107077QA - Method for detecting multispecific antibody light chain mispairing - Google Patents
Method for detecting multispecific antibody light chain mispairingInfo
- Publication number
- SG10202107077QA SG10202107077QA SG10202107077QA SG10202107077QA SG10202107077QA SG 10202107077Q A SG10202107077Q A SG 10202107077QA SG 10202107077Q A SG10202107077Q A SG 10202107077QA SG 10202107077Q A SG10202107077Q A SG 10202107077QA SG 10202107077Q A SG10202107077Q A SG 10202107077QA
- Authority
- SG
- Singapore
- Prior art keywords
- detecting
- light chain
- antibody light
- multispecific antibody
- chain mispairing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/6857—Antibody fragments
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14163165 | 2014-04-02 | ||
| EP15155361 | 2015-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202107077QA true SG10202107077QA (en) | 2021-07-29 |
Family
ID=52774264
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201608054YA SG11201608054YA (en) | 2014-04-02 | 2015-04-01 | Method for detecting multispecific antibody light chain mispairing |
| SG10202107077QA SG10202107077QA (en) | 2014-04-02 | 2015-04-01 | Method for detecting multispecific antibody light chain mispairing |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201608054YA SG11201608054YA (en) | 2014-04-02 | 2015-04-01 | Method for detecting multispecific antibody light chain mispairing |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20170115304A1 (en) |
| EP (2) | EP3126389B1 (en) |
| JP (1) | JP6666262B2 (en) |
| KR (1) | KR102376287B1 (en) |
| CN (2) | CN106164288A (en) |
| SG (2) | SG11201608054YA (en) |
| WO (1) | WO2015150446A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2537100T3 (en) | 2009-04-07 | 2015-06-02 | Roche Glycart Ag | Trivalent bispecific antibodies |
| EP3227332B1 (en) | 2014-12-03 | 2019-11-06 | F.Hoffmann-La Roche Ag | Multispecific antibodies |
| AU2019255270A1 (en) * | 2018-04-17 | 2020-11-19 | Invenra Inc. | Trivalent trispecific antibody constructs |
| CA3121699A1 (en) * | 2018-12-05 | 2020-06-11 | Morphosys Ag | Multispecific antigen-binding molecules |
| EP4437344A1 (en) * | 2021-11-25 | 2024-10-02 | F. Hoffmann-La Roche AG | Quantification of low amounts of antibody sideproducts |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| DK0564531T3 (en) | 1990-12-03 | 1998-09-28 | Genentech Inc | Enrichment procedure for variant proteins with altered binding properties |
| CA2103059C (en) | 1991-06-14 | 2005-03-22 | Paul J. Carter | Method for making humanized antibodies |
| CA2116774C (en) | 1991-09-19 | 2003-11-11 | Paul J. Carter | Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| US5747654A (en) | 1993-06-14 | 1998-05-05 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| JP4213224B2 (en) | 1997-05-02 | 2009-01-21 | ジェネンテック，インコーポレーテッド | Method for producing multispecific antibody having heteromultimer and common component |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6610833B1 (en) | 1997-11-24 | 2003-08-26 | The Institute For Human Genetics And Biochemistry | Monoclonal human natural antibodies |
| EP1034298B1 (en) | 1997-12-05 | 2011-11-02 | The Scripps Research Institute | Humanization of murine antibody |
| WO1999037791A1 (en) | 1998-01-23 | 1999-07-29 | Vlaams Interuniversitair Instituut Voor Biotechnologie | Multipurpose antibody derivatives |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| ES2248127T3 (en) | 1999-10-04 | 2006-03-16 | Medicago Inc. | METHOD FOR REGULATING THE TRANSCRIPTION OF FOREIGN GENES IN THE PRESENCE OF NIGTROGEN. |
| US20030180714A1 (en) | 1999-12-15 | 2003-09-25 | Genentech, Inc. | Shotgun scanning |
| MXPA02010011A (en) | 2000-04-11 | 2003-04-25 | Genentech Inc | Multivalent antibodies and uses therefor. |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| DE60131456T2 (en) | 2000-11-30 | 2008-07-10 | Medarex, Inc., Milpitas | TRANCHROMOSOMAL TRANSGEN RODENTS FOR THE MANUFACTURE OF HUMAN ANTIBODIES |
| EP1513879B1 (en) | 2002-06-03 | 2018-08-22 | Genentech, Inc. | Synthetic antibody phage libraries |
| EP1585767A2 (en) | 2003-01-16 | 2005-10-19 | Genentech, Inc. | Synthetic antibody phage libraries |
| US20050164402A1 (en) | 2003-07-14 | 2005-07-28 | Belisle Christopher M. | Sample presentation device |
| US7329353B2 (en) * | 2004-01-23 | 2008-02-12 | Amgen Inc. | LC/MS method of analyzing high molecular weight proteins |
| BRPI0508761A (en) | 2004-03-31 | 2007-08-14 | Genentech Inc | humanized antibody, composition comprising a humanized antibody, isolated nucleic acid, vector, host cell, humanized antibody production process, tgf-beta dysfunction treatment method, tgf-beta detection method, manufactured article and method of treating cancer |
| US7785903B2 (en) | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| SG156672A1 (en) | 2004-10-22 | 2009-11-26 | Amgen Inc | Methods for refolding of recombinant antibodies |
| CA2599265A1 (en) | 2005-02-28 | 2006-09-08 | Centocor, Inc. | Heterodimeric protein binding compositions |
| JP5620626B2 (en) | 2005-03-31 | 2014-11-05 | 中外製薬株式会社 | Polypeptide production method by association control |
| ES2577292T3 (en) | 2005-11-07 | 2016-07-14 | Genentech, Inc. | Binding polypeptides with diversified VH / VL hypervariable sequences and consensus |
| EP1973951A2 (en) | 2005-12-02 | 2008-10-01 | Genentech, Inc. | Binding polypeptides with restricted diversity sequences |
| EP1999154B1 (en) | 2006-03-24 | 2012-10-24 | Merck Patent GmbH | Engineered heterodimeric protein domains |
| WO2007134050A2 (en) | 2006-05-09 | 2007-11-22 | Genentech, Inc. | Binding polypeptides with optimized scaffolds |
| JP2009541275A (en) | 2006-06-22 | 2009-11-26 | ノボ・ノルデイスク・エー／エス | Production of bispecific antibodies |
| WO2008027236A2 (en) | 2006-08-30 | 2008-03-06 | Genentech, Inc. | Multispecific antibodies |
| CN100592373C (en) | 2007-05-25 | 2010-02-24 | 群康科技(深圳)有限公司 | Liquid crystal display panel driving device and driving method thereof |
| JP2011522213A (en) * | 2007-11-22 | 2011-07-28 | シムフォゲン・アクティーゼルスカブ | Methods for characterization of recombinant polyclonal proteins |
| US8242247B2 (en) | 2007-12-21 | 2012-08-14 | Hoffmann-La Roche Inc. | Bivalent, bispecific antibodies |
| US8227577B2 (en) | 2007-12-21 | 2012-07-24 | Hoffman-La Roche Inc. | Bivalent, bispecific antibodies |
| US20090162359A1 (en) | 2007-12-21 | 2009-06-25 | Christian Klein | Bivalent, bispecific antibodies |
| US9266967B2 (en) | 2007-12-21 | 2016-02-23 | Hoffmann-La Roche, Inc. | Bivalent, bispecific antibodies |
| PT2235064E (en) | 2008-01-07 | 2016-03-01 | Amgen Inc | Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| CN102369215B (en) | 2009-04-02 | 2015-01-21 | 罗切格利卡特公司 | Multispecific antibodies comprising full length antibodies and single chain fab fragments |
| ES2537100T3 (en) | 2009-04-07 | 2015-06-02 | Roche Glycart Ag | Trivalent bispecific antibodies |
| CA2759233C (en) | 2009-04-27 | 2019-07-16 | Oncomed Pharmaceuticals, Inc. | Method for making heteromultimeric molecules |
| BRPI1007602A2 (en) | 2009-05-27 | 2016-02-16 | Hoffmann La Roche | "tri or tetraspecific antibody, method for preparing a trispecific or tetraspecific antibody, host cell, composition, pharmaceutical composition and method for treating a patient in need of therapy" |
| US9676845B2 (en) | 2009-06-16 | 2017-06-13 | Hoffmann-La Roche, Inc. | Bispecific antigen binding proteins |
| US8703132B2 (en) | 2009-06-18 | 2014-04-22 | Hoffmann-La Roche, Inc. | Bispecific, tetravalent antigen binding proteins |
| WO2011090762A1 (en) | 2009-12-29 | 2011-07-28 | Emergent Product Development Seattle, Llc | Heterodimer binding proteins and uses thereof |
| JP6022444B2 (en) | 2010-05-14 | 2016-11-09 | ライナット ニューロサイエンス コーポレイション | Heterodimeric protein and method for producing and purifying it |
| ES2758994T3 (en) | 2010-11-05 | 2020-05-07 | Zymeworks Inc | Stable heterodimeric antibody design with mutations in the Fc domain |
| TR201815863T4 (en) | 2010-11-30 | 2018-11-21 | Chugai Pharmaceutical Co Ltd | Therapeutic agent that induces cytotoxicity. |
| AU2012235758B2 (en) | 2011-03-25 | 2015-05-07 | IGI Therapeutics SA | Hetero-dimeric immunoglobulins |
| CN103827300A (en) | 2011-06-30 | 2014-05-28 | 中外制药株式会社 | heterodimeric polypeptide |
| US9738707B2 (en) | 2011-07-15 | 2017-08-22 | Biogen Ma Inc. | Heterodimeric Fc regions, binding molecules comprising same, and methods relating thereto |
| MX2014001799A (en) | 2011-08-23 | 2014-03-31 | Roche Glycart Ag | Fc-free antibodies comprising two fab fragments and methods of use. |
| ES2816078T3 (en) | 2011-12-20 | 2021-03-31 | Medimmune Llc | Modified Polypeptides for Bispecific Antibody Scaffolds |
| MX2014011818A (en) * | 2012-04-05 | 2014-12-10 | Hoffmann La Roche | Bispecific antibodies against human tweak and human il17 and uses thereof. |
| ES2740749T3 (en) | 2012-04-20 | 2020-02-06 | Merus Nv | Methods and means for the production of Ig-like heterodimeric molecules |
| WO2013174873A1 (en) | 2012-05-24 | 2013-11-28 | F. Hoffmann-La Roche Ag | Multispecific antibodies |
| UY35148A (en) * | 2012-11-21 | 2014-05-30 | Amgen Inc | HETERODIMERIC IMMUNOGLOBULINS |
| US9914785B2 (en) | 2012-11-28 | 2018-03-13 | Zymeworks Inc. | Engineered immunoglobulin heavy chain-light chain pairs and uses thereof |
| WO2014121031A1 (en) * | 2013-01-31 | 2014-08-07 | Excelimmune, Inc. | Characterization of antibody mixtures by mass spectrometry |
-
2015
- 2015-04-01 EP EP15712970.1A patent/EP3126389B1/en active Active
- 2015-04-01 CN CN201580018014.9A patent/CN106164288A/en active Pending
- 2015-04-01 JP JP2016560359A patent/JP6666262B2/en active Active
- 2015-04-01 CN CN202110521522.6A patent/CN113092788A/en active Pending
- 2015-04-01 EP EP24207684.2A patent/EP4570917A3/en active Pending
- 2015-04-01 KR KR1020167028373A patent/KR102376287B1/en not_active Expired - Fee Related
- 2015-04-01 SG SG11201608054YA patent/SG11201608054YA/en unknown
- 2015-04-01 WO PCT/EP2015/057164 patent/WO2015150446A1/en not_active Ceased
- 2015-04-01 SG SG10202107077QA patent/SG10202107077QA/en unknown
-
2016
- 2016-09-28 US US15/278,242 patent/US20170115304A1/en not_active Abandoned
-
2019
- 2019-05-20 US US16/417,150 patent/US11486882B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017509669A (en) | 2017-04-06 |
| CN106164288A (en) | 2016-11-23 |
| KR20160140723A (en) | 2016-12-07 |
| WO2015150446A1 (en) | 2015-10-08 |
| US20170115304A1 (en) | 2017-04-27 |
| JP6666262B2 (en) | 2020-03-13 |
| EP4570917A2 (en) | 2025-06-18 |
| US20200103413A1 (en) | 2020-04-02 |
| EP3126389A1 (en) | 2017-02-08 |
| SG11201608054YA (en) | 2016-10-28 |
| US11486882B2 (en) | 2022-11-01 |
| EP3126389B1 (en) | 2024-10-23 |
| KR102376287B1 (en) | 2022-03-17 |
| EP4570917A3 (en) | 2025-09-03 |
| CN113092788A (en) | 2021-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL255198B (en) | Purification platform for bispecific antibodies | |
| GB201621919D0 (en) | Method for detecting wellbore influx | |
| ZA201605660B (en) | Multispecific antibodies | |
| PL3227332T3 (en) | Multispecific antibodies | |
| GB201414823D0 (en) | Multispecific antibodies | |
| PT2975686T (en) | RECYCLING METHOD | |
| IL246889A0 (en) | Method for measuring engagement | |
| SG11201701015QA (en) | Optical concentration measuring method | |
| EP3146079A4 (en) | Methods for determining lymphocyte receptor chain pairs | |
| SG10201500862RA (en) | A Method for Detecting a Target Analyte | |
| IL253579A0 (en) | Anti-surrogate light chain antibodies | |
| DK3206586T3 (en) | METHOD FOR DETECTING DICROTIC CHICKEN | |
| SG11201701875YA (en) | Methods for detecting ovarian cancer | |
| FR3020157B1 (en) | DIGITAL DETECTION METHOD | |
| BR112016026476A2 (en) | CHAIN BLOCK | |
| GB201515693D0 (en) | Method for antigen detection | |
| SG10202107077QA (en) | Method for detecting multispecific antibody light chain mispairing | |
| LU92498B1 (en) | Method for transport analysis | |
| IL251902A0 (en) | A method for detecting defective pixels | |
| EP3217173A4 (en) | Method for detecting disease | |
| SG11201608175SA (en) | Efficient line search methods for multi-parameter full wavefield inversion | |
| GB201419113D0 (en) | Method for determining diffusion | |
| EP3173791A4 (en) | Method for determining pancreatic disease | |
| EP3342590A4 (en) | METHOD FOR EMBELLING AN ENBALSA AEROMODEL | |
| PL3025781T3 (en) | A method for determinig agglutination |